EUROAPI acquired BianoGMP, strengthening its contract development and manfacturing organization (CDMO) expertise in the high-growth oligonucleotide market. According to the company, the acquisition further differentiates EUROAPI’s value proposition to support a broader client base across the whole oligonucleotide development continuum, from research to commercialization. Biano will retain its corporate brand and become a EUROAPI company. “We are delighted to welcome the talented people ...